Henlius Biotech in talks with J&J, Roche on cancer drug: report (SGBCF:OTCMKTS)

Core Insights - Shanghai Henlius Biotech is negotiating with major pharmaceutical companies, including Johnson & Johnson and Roche Holding AG, for the rights to an experimental cancer drug [1] Company Developments - The potential agreement with pharmaceutical giants indicates a strategic move for Shanghai Henlius Biotech to expand its market presence and leverage partnerships with established companies in the industry [1]